About
Loading Red-Blood Cells with Therapeutics
Areas of Focus
Categories
Biologics & BiopharmaceuticalSmall Molecule Pharmaceutical
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
3
As Collaborator
1
Total Enrollment
224
By Phase
PHASE2: 2PHASE1/PHASE2: 2
By Status
UNKNOWN: 3NOT_YET_RECRUITING: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT06605651Lead Sponsor
Proof of Concept Study to Assess Safety and Efficacy of Phage Therapy in Hip or Knee Prosthetic Joint Infections Due to Staphylococcus Aureus Treated by DAIR.
PHASE2Not yet recruiting
100 participants
Started: Jan 31, 2025 · Completed: Jan 31, 2027
NCT05369104Lead Sponsor
Phage Therapy in Prosthetic Joint Infection Due to Staphylococcus Aureus Treated With DAIR.
PHASE2Unknown
64 participants
Started: Jun 15, 2022 · Completed: Jun 16, 2025
NCT02664740Collaborator
Standard Treatment Associated With Phage Therapy Versus Placebo for Diabetic Foot Ulcers Infected by S. Aureus
PHASE1/PHASE2Unknown
60 participants
Started: Jun 1, 2022 · Completed: Aug 31, 2024
NCT02116010Lead Sponsor
Evaluation of Phage Therapy for the Treatment of Escherichia Coli and Pseudomonas Aeruginosa Wound Infections in Burned Patients
PHASE1/PHASE2Unknown
Started: Jul 31, 2015
Locations (1)
Headquarters
Lyon, France
Map
Loading map...